The Martha Olson-Fernandez Foundation is committed to funding innovative research that aims to develop effectual treatments and ultimately find a cure for amyotrophic lateral sclerosis. The foundation is dedicated to raising awareness of ALS and providing financial assistance to underserved patients on the Central Coast of California.
Martha, loving wife, mother, daughter, sister, and friend to all, battled ALS for two years before it took her life. She vowed to never give up and we promised to fight for her, and all other victims of this relentless disease, until a cure is found.
~BE BRAVE AND STRONG~
(February 1963-December 2012)
The Martha Olson-Fernandez Foundation supports ALS Therapy Development Institute (ALS TDI) to complete our mission of funding cutting edge ALS research. ALS TDI is an incredibly driven non profit biotech company founded by the Heyward brothers in 1999. ALS TDI is located in Cambridge, MA and has intimate ties to the pharmaceutical industry, thus providing influence and actionability when it comes to testing and developing molecules for ALS treatment. We trust ALS TDI to be the most accurate, efficient and reliable source of ALS research. Below is a detailed timeline of our donations to ALS TDI.
2016: MOFF chose to dedicate $20,000 of our donor dollars to go toward ALS TDI’s research on the C9orf72 gene.
2017: MOFF donated $25,000 toward the drug development of AT-1501 which is currently in the preclinical drug development stage.
2018: MOFF has promised $25,000 to be donated to ALS TDI’s mission of building up their blood and tissue sample bank in order to seek out biomarkers to identify and track disease progression in ALS. Identifying biomarkers is a preliminary, critical step in developing a treatment and cure for ALS.